Sihuan Pharmaceutical Holdings Group Ltd. (HKG:0460)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Generic Medicine	956.32M	1.10B	1.40B	1.97B	2.60B
Innovative Medicine and Other Medicine	232.42M	109.67M	36.77M	165.71M	105.11M
Medical Aesthetic Products	1.49B	744.22M	449.91M	149.78M	398.95M
Elimination of Intersegment Sales	-56.00M	-52.08M	-24.99M	-104.80M	-63.81M
Total	2.62B	1.90B	1.86B	2.18B	3.04B

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Mainland China	2.60B	1.89B	1.85B	2.17B	3.04B
United States of America	13.10M	12.56M	13.79M	14.41M	-
Others	342.00K	-	-	-	-
Total	2.62B	1.90B	1.86B	2.18B	3.04B

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 27, 2026

Data Sources Report a data error